Related Experiment Video
Updated: Apr 28, 2026

06:19
Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
1.9K
Ab interno approach to the subconjunctival space using a collagen glaucoma stent
1From a private practice, Sacramento, California, USA.
Journal of Cataract and Refractive Surgery
|June 20, 2014
Summary
A new collagen implant (XEN gel stent) offers a minimally invasive surgical option for glaucoma, creating a drainage pathway to reduce intraocular pressure (IOP) with improved safety and long-term efficacy.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Glaucoma Treatment
Background:
- Glaucoma filtration surgery aims to lower intraocular pressure (IOP) by creating artificial aqueous fluid drainage pathways.
- Traditional methods carry significant short- and long-term complications.
- Minimally invasive techniques are sought to improve safety and efficacy.
Purpose of the Study:
- To review the development and characteristics of a novel, soft, permanent ab interno collagen implant (XEN gel stent).
- To evaluate its potential for optimizing aqueous drainage in glaucoma surgery.
- To assess its safety and efficacy as a minimally invasive alternative.
Main Methods:
- Description of the XEN gel stent, focusing on critical design characteristics (lumen size, material, dimensions, flexibility, stability, biocompatibility).
- Review of preclinical and human eye testing data.
- Analysis of the ab interno surgical approach for stent placement.
Main Results:
- The XEN gel stent is designed to balance hypotony avoidance with maximal long-term outflow.
- Preclinical and human testing indicate no observed lumen occlusion.
- The implant material shows no apparent tissue reaction within the eye.
Conclusions:
- The ab interno XEN gel stent provides a minimally invasive approach to glaucoma surgery.
- It offers reduced conjunctival disruption and controlled flow to prevent hypotony.
- The implant demonstrates potential for long-term IOP reduction and safety.
More Related Videos
Related Concept Videos
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K

